Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Human Gene Therapy|March 11, 2026
Morphological and Molecular Detection of AAV Vector Genome and Transgene mRNA in the Oocytes of Female Cynomolgus Monkey Following Systemic Intravenous AdministrationBasel T Assaf, Joshua G DeKeyser
Archives of Biochemistry and Biophysics|September 5, 2006
Studies on titin PEVK peptides and their interactionYingli Duan, Joshua G DeKeyser, Srinivasan Damodaran, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 30, 2006
CAR2 displays unique ligand binding and RXRalpha heterodimerization characteristicsScott S Auerbach, Joshua G Dekeyser, Matthew A Stoner, et al.
Rapid Communications in Mass Spectrometry : RCM|November 17, 2010
Bioassay-directed fractionation for discovery of bioactive neutral lipids guided by relative mass defect filtering and multiplexed collision-induced dissociationMichael C Stagliano, Joshua G DeKeyser, Curtis J Omiecinski, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|January 14, 2011
Selective phthalate activation of naturally occurring human constitutive androstane receptor splice variants and the pregnane X receptorJoshua G DeKeyser, Elizabeth M Laurenzana, Eric C Peterson, et al.
Molecular Pharmacology|February 13, 2009
Di(2-ethylhexyl) phthalate is a highly potent agonist for the human constitutive androstane receptor splice variant CAR2Joshua G DeKeyser, Michael C Stagliano, Scott S Auerbach, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 2018
Considerations from the Innovation and Quality Induction Working Group in Response to Drug-Drug Interaction Guidances from Regulatory Agencies: Focus on CYP3A4 mRNA In Vitro Response Thresholds, Variability, and Clinical RelevanceJane R Kenny, Diane Ramsden, David B Buckley, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 25, 2017
Considerations from the IQ Induction Working Group in Response to Drug-Drug Interaction Guidance from Regulatory Agencies: Focus on Downregulation, CYP2C Induction, and CYP2B6 Positive ControlNiresh Hariparsad, Diane Ramsden, Jairam Palamanda, et al.
Pageof 1